Merck KGaA to Close Merck Serono Site in Geneva, Cut Jobs

Merck plans to close the Geneva headquarters of its Serono unit, five years after buying Europe’s biggest biotechnology company for about $13.3 billion to expand a drug business that has since faced development and regulatory setbacks. Bloomberg